Lung Cancer Clinical Trial

The Transitions Project: Efficacy Trial

Summary

The aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.

View Full Description

Full Description

This is a randomized controlled trial to test the efficacy of a brief psychoeducational intervention relative to a control condition for improving quality of life in patients with lung cancer who are transitioning from treatment to surveillance.

In this study, participants will complete survey questions and will be randomly assigned to receive a 5-session program or a 1-session program.

It is expected that about 100 people will take part in this research study.

The American Lung Association is supporting this research by providing funding for the research study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age 21 or older
Able to read and respond in English
Diagnosis of non-small cell lung cancer or small cell lung cancer
Documented curative treatment plan including systemic therapy +/- radiation and +/- surgery

Completed cancer treatment within past 3 weeks

If final treatment is systemic therapy +/- radiation: within 3 weeks after cancer care team determination that treatment is complete
If final treatment is surgery: within 3 weeks after hospital discharge following surgery

Exclusion Criteria:

Comorbid health condition that would interfere with study participation
Current participation in cognitive behavioral therapy treatment

Study is for people with:

Lung Cancer

Estimated Enrollment:

100

Study ID:

NCT05087251

Recruitment Status:

Recruiting

Sponsor:

Massachusetts General Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Massachusetts General Hospital Cancer Center
Boston Massachusetts, 02114, United States More Info
Lara Traeger, PhD
Contact
617-643-4314
[email protected]
Lara Traeger, PhD
Principal Investigator
Dana-Farber Cancer Institute
Boston Massachusetts, 02215, United States More Info
Sharon Bober, PhD
Contact
617-632-6547
[email protected]
Timothy Sannes, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

100

Study ID:

NCT05087251

Recruitment Status:

Recruiting

Sponsor:


Massachusetts General Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.